Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

325
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
325
Cancer Survival Analysis01:21

Cancer Survival Analysis

345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

980
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
980
Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Length Effect on the Stress Detection of Prestressed Steel Strands Based on Electromagnetic Oscillation Method.

Sensors (Basel, Switzerland)·2019
Same author

Electrocatalytic oxidation toward dopamine and acetaminophen based on AuNPs@TCnA/GN modified glassy carbon electrode.

Analytica chimica acta·2019
Same author

Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF Status.

The American journal of surgical pathology·2019
Same author

A data review of airway management in patients with oral cavity or oropharyngeal cancer: a single-institution experience.

BMC anesthesiology·2019
Same author

Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2019
Same author

Mantle Cell Lymphoma With Mantle Zone Growth Pattern.

American journal of clinical pathology·2019

Related Experiment Video

Updated: Jun 26, 2025

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.1K

Conditional survival of patients with primary bone lymphoma of the spine: how survival changes after initial

Gang Zheng1, Zhihao Yang1, Hui Qian1

  • 1Department of Neurosurgery, Shaoxing Central Hospital, The Central Hospital of Shaoxing University, Shaoxing, Zhejiang, China.

Frontiers in Oncology
|May 16, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces conditional survival (CS) to predict outcomes for spinal primary bone lymphoma (PBL). A new CS-based nomogram offers real-time survival predictions, improving personalized treatment for spinal PBL patients.

Keywords:
SEERSEER primary bone lymphoma of the spineconditional survivalnomogramprimary bone lymphoma of the spinesurvival estimation

More Related Videos

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.7K
Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
05:39

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Published on: December 27, 2024

370

Related Experiment Videos

Last Updated: Jun 26, 2025

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.1K
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.7K
Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
05:39

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Published on: December 27, 2024

370

Area of Science:

  • Oncology
  • Biostatistics
  • Medical Informatics

Background:

  • Existing survival prediction methods for spinal primary bone lymphoma (PBL) are inadequate.
  • This research pioneers the use of conditional survival (CS) for assessing spinal PBL outcomes.
  • The study aims to develop a CS-based nomogram for real-time overall survival (OS) prediction in spinal PBL.

Purpose of the Study:

  • To evaluate the utility of conditional survival (CS) in predicting outcomes for spinal primary bone lymphoma (PBL).
  • To develop and validate a novel nomogram for real-time, dynamic overall survival (OS) prediction in spinal PBL.
  • To establish a risk stratification system for identifying high-risk spinal PBL patients.

Main Methods:

  • Utilized data from the Surveillance, Epidemiology, and End Results (SEER) database (2000-2015) for spinal PBL patients.
  • Calculated conditional survival (CS) using the formula: CS(α|β) = OS(α+β)/OS(β).
  • Employed univariate Cox regression, best subset regression (BSR), and LASSO regression to identify predictors for nomogram construction.

Main Results:

  • Kaplan-Meier analysis showed 3-year and 5-year OS rates of 68% and 63%, respectively.
  • Conditional survival (CS) analysis revealed progressively improving survival for spinal PBL over time.
  • Identified key predictors for survival: age, tumor histology, tumor stage, chemotherapy, and marital status.

Conclusions:

  • This is the first study to analyze the conditional survival (CS) pattern in spinal primary bone lymphoma (PBL).
  • A novel CS-based nomogram was developed, providing dynamic, real-time prognostic data.
  • The nomogram and risk stratification system can aid in personalized treatment strategies and identification of high-risk patients.